Male Infertility Market Is Projected To Grow Due To Increasing Infertility In Male & Advancements In Diagnostic Tests Till 2025: Grand View Research, Inc.
The global male infertility market is
expected to reach USD 4.7 billion by 2025, according to a new report by Grand
View Research, Inc. Globally, increasing infertility in male and advancements
in diagnostic tests have been major factors driving the market growth. In
addition, growing consciousness regarding factors causing male infertility and
Assisted Reproductive Technology (ART) has led to increased adoption of treatment.
Furthermore, increasing aging
population, rising obesity, and other lifestyle-associated diseases causing
infertility are likely to boost the market during the forecast period. In the
U.S., one third of infertility cases are due to female factor, one third due to
male factors, and remaining one third are unexplained.
DNA fragmentation technique was
the largest segment in male infertility tests market in 2016 and is expected to
maintain its dominance during the forecast period due to rapid growth in next
few years. High cost and increasing adoption in developed countries due to
higher sensitivity and reliable analysis of sperm DNA integrity are the key
factors for its dominance.
In 2016, ART segment dominated in
the treatment market due to high success rate. In Vitro Fertilization and
Intracytoplasmic Sperm Injection (ICSI) are the major ARTs used. Medications
include corticosteroids and hormonal therapy; however, they are effective in
very few cases. Hence, low demand, less adherence, and lower cost as compared
to ART are likely to slow the growth of the medication market.
Browse full research report on Male Infertility Market: http://www.grandviewresearch.com/industry-analysis/male-infertility-market
Further Key Findings From the Report Suggest:
- Rising demand of ARTs across the globe is expected to
propel growth at the fastest rate from 2017 to 2025
- DNA fragmentation technique for the testing of male
infertility dominated in 2016 and is estimated to generate revenue at a
rapid rate over the forecast period.
- Oxidative stress analysis is another method gaining
popularity due to accurate determination of reactive oxygen species. The
test accounted second largest share in the testing market.
- The Europe market was the largest in 2016 and is
expected to maintain its dominance during forecast period due to higher
awareness, strong diagnosis rate, and high adoption of costlier treatment.
- The industry in Asia Pacific is projected to witness
substantial growth over the next decade owing to growing investment by
several clinics and pharmaceutical companies in the region, and increasing
healthcare expenditure.
- Some key players include EMD Sereno, Inc.; Aytu
BioScience, Inc.; Bayer Healthcare; Cadila Healthcare Ltd.; Intas
Pharmaceuticals Ltd.; Halotech DNA SL; SCSA diagnostics, Inc.; and
Andrology Solutions. However, EMD Sereno, Inc. currently dominates the
male infertility market.
Browse more reports of this category by Grand View
Research: http://www.grandviewresearch.com/industry/healthcare
Grand View Research has segmented the global male
infertility market on the basis of test, treatment, and region:
Male Infertility Test Outlook (Revenue, USD
Million, 2014 - 2025)
- DNA
Fragmentation Technique
- Oxidative
Stress Analysis
- Microscopic
Examination
- Sperm
Agglutination
- Computer
Assisted Semen Analysis
- Sperm
Penetration Assay
- Others
Male Infertility Treatment Outlook (Revenue, USD Million,
2014 - 2025)
- Assisted
Reproductive Technology
- Medication
Male Infertility Regional Outlook (Revenue, USD Million,
2014 - 2025)
- North
America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- Asia
Pacific
- Japan
- China
- Central
& South America
- Brazil
- Mexico
- Middle
East & Africa
- South
Africa
Access Press Release
By Grand View Research: http://www.grandviewresearch.com/press-release/global-male-infertility-market
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides
syndicated research reports, customized research reports, and consulting
services. To help clients make informed business decisions, we offer market
intelligence studies ensuring relevant and fact-based research across a range
of industries, from technology to chemicals, materials and healthcare.
Comments
Post a Comment